CMC Biologics Enters into Development and Manufacturing Agreement with Trellis BioScience
Development of Trellis’ monoclonal antibody (mAb) using CMC Biologics’ proprietary CHEF1® Expression Platform and Multi-column Continuous Chromatography (M...




